MedElevator
Войти в исследования Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
Gut microbiota-metabolite crosstalk mediates icariin's protection against obesity-induced spermatogenic dysfunction through NF-κB/AMH axis in Sertoli cells.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Huang Qiumei, Ji Lin, Meng Zhuoxiao, Huang Kongwei, Lei Siyuan, Xue Haoxuan, Zhou Qian, Tian Yihang, Chen Toutou, Lei Xiaocan, Huang Hua
Аннотация
BACKGROUND: Chronic inflammation caused by obesity is a major contributor to male infertility, yet effective therapeutic options remain limited. Icariin (ICA), a flavonoid from Epimedium, shows anti-inflammatory and reproductive-protective properties. This study aims to investigate the mechanisms by which ICA ameliorates obesity-associated spermatogenic impairment.
METHODS: A high-fat diet (HFD) mouse model was developed and treated with ICA. Multi-omics approaches, including serum metabolomics, gut microbiota profiling, and testicular transcriptomics, were combined with bioinformatics tools (WGCNA, GSEA, KEGG, and network pharmacology). Key targets and pathways were validated by qRT-PCR, Western blotting, immunohistochemistry, immunofluorescence, and CETSA assays.
RESULTS: ICA treatment improved testicular morphology, enhanced spermatogenesis, and restored serum AMH levels. Metabolomic analysis revealed that ICA reduced the levels of pro-inflammatory metabolites (7-ketocholesterol, 8(S),15(S)-DiHETE, aldosterone) and increased the levels of anti-inflammatory metabolites (resveratrol, folic acid, eicosapentaenoic acid). Microbiota-metabolite correlations indicated that ICA enriched Akkermansia and suppressed pro-inflammatory Helicobacteraceae, which reshaped the gut-metabolite-inflammation axis. Transcriptomic analysis revealed that ICA suppressed HFD-induced activation of IL-1β, TNF-α, and NF-κB signaling, accompanied by recovery of AMH-related regulators (SF-1, SOX9, GATA4, WT-1). Network pharmacology further identified NF-κB as a core target of ICA. CETSA and co-localization assays confirmed the direct interaction between ICA and NF-κB.
CONCLUSION: ICA alleviates obesity-induced spermatogenic impairment by inhibiting NF-κB-mediated inflammation and restoring AMH synthesis, partially through microbiota-metabolite modulation. These findings highlight that ICA serves as a promising therapeutic candidate for obesity-related male infertility.
METHODS: A high-fat diet (HFD) mouse model was developed and treated with ICA. Multi-omics approaches, including serum metabolomics, gut microbiota profiling, and testicular transcriptomics, were combined with bioinformatics tools (WGCNA, GSEA, KEGG, and network pharmacology). Key targets and pathways were validated by qRT-PCR, Western blotting, immunohistochemistry, immunofluorescence, and CETSA assays.
RESULTS: ICA treatment improved testicular morphology, enhanced spermatogenesis, and restored serum AMH levels. Metabolomic analysis revealed that ICA reduced the levels of pro-inflammatory metabolites (7-ketocholesterol, 8(S),15(S)-DiHETE, aldosterone) and increased the levels of anti-inflammatory metabolites (resveratrol, folic acid, eicosapentaenoic acid). Microbiota-metabolite correlations indicated that ICA enriched Akkermansia and suppressed pro-inflammatory Helicobacteraceae, which reshaped the gut-metabolite-inflammation axis. Transcriptomic analysis revealed that ICA suppressed HFD-induced activation of IL-1β, TNF-α, and NF-κB signaling, accompanied by recovery of AMH-related regulators (SF-1, SOX9, GATA4, WT-1). Network pharmacology further identified NF-κB as a core target of ICA. CETSA and co-localization assays confirmed the direct interaction between ICA and NF-κB.
CONCLUSION: ICA alleviates obesity-induced spermatogenic impairment by inhibiting NF-κB-mediated inflammation and restoring AMH synthesis, partially through microbiota-metabolite modulation. These findings highlight that ICA serves as a promising therapeutic candidate for obesity-related male infertility.